Literature DB >> 16710167

Screening of the MERTK gene for mutations in Japanese patients with autosomal recessive retinitis pigmentosa.

Asako Tada1, Yuko Wada, Hajime Sato, Toshitaka Itabashi, Miyuki Kawamura, Makoto Tamai, Kohji Nishida.   

Abstract

PURPOSE: To determine whether mutations in the MERTK gene are present in Japanese patients with autosomal recessive retinitis pigmentosa (arRP).
METHODS: The coding sequence of all 19 exons and the adjacent flanking intron sequences of the MERTK gene were directly sequenced in 96 unrelated Japanese patients with arRP.
RESULTS: Seventeen sequence variants were found; six missense changes, three isocoding changes, and eight intron changes were also observed. One arRP patient had a novel homozygous Leu12Pro missense mutation in the MERTK gene.
CONCLUSIONS: Mutations in the MERTK gene are relatively rare in Japanese patients with arRP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710167

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  9 in total

1.  Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats.

Authors:  Wen-Tao Deng; Astra Dinculescu; Qiuhong Li; Sanford L Boye; Jie Li; Marina S Gorbatyuk; Jijing Pang; Vince A Chiodo; Michael T Matthes; Douglas Yasumura; Li Liu; Fowzan S Alkuraya; Kang Zhang; Douglas Vollrath; Matthew M LaVail; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-06       Impact factor: 4.799

2.  Novel mutations in MERTK associated with childhood onset rod-cone dystrophy.

Authors:  Donna S Mackay; Robert H Henderson; Panagiotis I Sergouniotis; Zheng Li; Phillip Moradi; Graham E Holder; Naushin Waseem; Shomi S Bhattacharya; Mohammed A Aldahmesh; Fowzan S Alkuraya; Brian Meyer; Andrew R Webster; Anthony T Moore
Journal:  Mol Vis       Date:  2010-03-09       Impact factor: 2.367

Review 3.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

4.  A novel MERTK deletion is a common founder mutation in the Faroe Islands and is responsible for a high proportion of retinitis pigmentosa cases.

Authors:  Elsebet Ostergaard; Morten Duno; Mustafa Batbayli; Kaj Vilhelmsen; Thomas Rosenberg
Journal:  Mol Vis       Date:  2011-06-04       Impact factor: 2.367

Review 5.  Advances in gene therapy technologies to treat retinitis pigmentosa.

Authors:  Hilda Petrs-Silva; Rafael Linden
Journal:  Clin Ophthalmol       Date:  2013-12-24

6.  Tyro3 Modulates Mertk-Associated Retinal Degeneration.

Authors:  Douglas Vollrath; Douglas Yasumura; Gillie Benchorin; Michael T Matthes; Wei Feng; Natalie M Nguyen; Cecilia D Sedano; Melissa A Calton; Matthew M LaVail
Journal:  PLoS Genet       Date:  2015-12-11       Impact factor: 5.917

7.  RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells.

Authors:  George Inana; Christopher Murat; Weijun An; Xiang Yao; Ian R Harris; Jing Cao
Journal:  J Transl Med       Date:  2018-03-13       Impact factor: 5.531

8.  Structural insights into the inhibited states of the Mer receptor tyrosine kinase.

Authors:  Xudong Huang; Patrick Finerty; John R Walker; Christine Butler-Cole; Masoud Vedadi; Matthieu Schapira; Sirlester A Parker; Benjamin E Turk; Debra A Thompson; Sirano Dhe-Paganon
Journal:  J Struct Biol       Date:  2008-11-05       Impact factor: 2.867

9.  A novel start codon mutation of the MERTK gene in a patient with retinitis pigmentosa.

Authors:  Worapoj Jinda; Naravat Poungvarin; Todd D Taylor; Yutaka Suzuki; Wanna Thongnoppakhun; Chanin Limwongse; Patcharee Lertrit; Prapat Suriyaphol; La-Ongsri Atchaneeyasakul
Journal:  Mol Vis       Date:  2016-04-21       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.